Veness Adam M
5 of 9 shown
The 5 most recent of 9 visible filings, newest first.
- Dianthus Therapeutics, Inc. /DE/ SVP, General Counsel and Sec.15,000 sharesOption exercise
- Dianthus Therapeutics, Inc. /DE/ SVP, General Counsel and Sec.$272,550Option exercise
- Dianthus Therapeutics, Inc. /DE/ SVP, General Counsel and Sec.16,167 sharesOption exercise
- Dianthus Therapeutics, Inc. /DE/ SVP, General Counsel and Sec.$1,784,513Open-market sale
- Dianthus Therapeutics, Inc. /DE/ SVP, General Counsel and Sec.$289,066Option exercise